Cart
sales@molnova.com
10,11-Dihydrocarbamazepine
CAS No. 3564-73-6
10,11-Dihydrocarbamazepine( —— )
Catalog No. M14223 CAS No. 3564-73-6
Used as pharmaceutical intermediates.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 27 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name10,11-Dihydrocarbamazepine
-
NoteResearch use only, not for human use.
-
Brief DescriptionUsed as pharmaceutical intermediates.
-
DescriptionUsed as pharmaceutical intermediates.(In Vitro):Oxcarbazepine is metabolized in the liver to its active metabolite, 10,11-Dihydrocarbamazepine. Oxcarbazepine is an antiepileptic drug (AED) used to treat partial seizures as a monotherapy or adjunctive therapy.10,11-Dihydrocarbamazepine may be used as a reference standard for the determination of 10,11-dihydrocarbamazepine in pharmaceutical formulations by liquid chromatography (LC).
-
In VitroOxcarbazepine is metabolized in the liver to its active metabolite, 10,11-Dihydrocarbamazepine. Oxcarbazepine is an antiepileptic drug (AED) used to treat partial seizures as a monotherapy or adjunctive therapy. 10,11-Dihydrocarbamazepine may be used as a reference standard for the determination of 10,11-dihydrocarbamazepine in pharmaceutical formulations by liquid chromatography (LC).
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number3564-73-6
-
Formula Weight238.29
-
Molecular FormulaC15H14N2O
-
Purity>98% (HPLC)
-
SolubilityLimited solubility
-
SMILESNC(=O)N1C2=CC=CC=C2CCC2=CC=CC=C12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Eberlin AR, et al. Acta Crystallogr C. 2013 Nov;69(Pt 11):1260-6.
molnova catalog
related products
-
Teprotumumab
Teprotumumab is a human monoclonal antibody that blocks the IGF-1 receptor (IGF-1R). Teprotumumab binds to the extracellular α-subunit domain ligand of IGF-1R.
-
Bak BH3
This peptide, generated from the BH3 domain of Bak (Flu-BakBH3), has been shown to have high-affinity binding to a surface pocket of the Bcl-XL protein that is required for its death antagonist function.
-
Benorilate
Benorylate (Benoral) is the esterification product of paracetamol and acetylsalicylic acid. It has anti-inflammatory, analgesic and antipyretic properties. Benorylate could also inhibit prostaglandin (PG) synthesis.
